大麻二酚与抑郁症治疗:基于血脑屏障损伤修复的前沿机制探索OA
Cannabidiol and treatment of depression:an exploration of cutting-edge mechanisms based on blood-brain barrier repair
抑郁症是一种常见的精神疾病,其病理机制涉及单胺能系统失衡、神经炎症、氧化应激等多重因素.研究发现,抑郁症中也伴随一定程度的血脑屏障功能障碍.近年来,大麻二酚(CBD)因其显著的抗抑郁活性和神经保护特性受到广泛关注.尤其值得关注的是,CBD可能通过修复血脑屏障损伤,改善中枢神经系统的稳态,从而发挥治疗抑郁症的作用.该文结合近年研究成果,系统探讨CBD的抗抑郁机制、抑郁症中出现的血脑屏障损伤以及CBD对血脑屏障的保护作用,将为后续深入研究抑郁症中血脑屏障损伤的相关机制,发现新的抗抑郁靶点提供参考.
Depression is a common mental disorder,the pathogenesis of which involves such factors as the imbalance of the monoamine system,neuroinflammation,and oxidative stress.Depression has been found to be associated with dysfunction in the blood-brain barrier(BBB).In recent years,cannabidiol(CBD)has attracted extensive attention due to its remarkable antidepressant activity and neuroprotective properties.Of particular interest is the possibility that CBD may combat depression by repairing BBB damage and thereby improving the homeostasis of the central nervous system.Based on recent research findings,this article explores the antidepressant mechanisms of CBD,the BBB damage in depression,and the protective effects of CBD on the BBB.It is expected to provide references for subsequent studies on the mechanisms of BBB damage in depression and the discovery of new antidepressant targets.
陈悦;龙倩;江小霞;麻慧;乔鑫
南华大学衡阳医学院军事科学院军事医学研究院研究生协作培养基地,湖南 衡阳 421001军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850
医药卫生
大麻二酚抑郁症血脑屏障紧密连接蛋白神经炎症
cannabidioldepressionblood-brain barriertight junction proteinsneuroinflammation
《军事医学》 2026 (1)
58-63,6
北京市自然科学基金项目(7232348)国家自然科学基金项目(82204360)
评论